USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ART Medical Ltd.

USPTO PatentsView assignee record - 26 granted patents across 7 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

RSS updates for this company

The verdict

According to USPTO PatentsView, ART ranks #11,551 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 7 technology areas.

#11,551
of 49,997 US assignees by volume
Top 38%
by Innovation Score (39.4/100)
20.0
avg claims per patent
+2400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11551 · Foreign Corporation #11,551 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 26 grants
  • UPPER-Q #11,551/49,997
  • PHOTO-FINISH Amobee
  • CPC-NARROW A61J · 7 areas
  • INNOV-THIN 39.4/100
  • CLAIMS-DENSE 20.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +2400% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Amobee, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How ART’s 39.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around ART

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows ART's Innovation Score is 39.4/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for ART?

Each dot is one of ART’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). ART’s own 20.0 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

ART vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 25.92626.1 510152025 Granted patents (volume) Avg claims / patent Amobee, Inc. - 26, 18.04AmobeeAndreas Fahl Medizintechnik-vertrieb GMBH - 26, 6.35Andreas Fahl Medi…AOD Holdings, LLC - 26, 18.04AOD HoldingsAqua Co., Ltd. - 26, 8.04AquaArturo Salice S.P.A. - 26, 13.69Arturo Salice S P…Assa Abloy Access and Egress Hardware Group, Inc. - 26, 8.42Assa Abloy Access…Astrium SAS - 26, 13.77Astrium SASAtomic Energy OF Canada LIMITED/ÈNERGIE Atomique DU Canada LIMITÈE - 26, 17.58Atomic Energy OF…ART Medical Ltd. - 26, 20ART Medical
ART vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where ART's grants concentrate

ART Medical Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 84.6% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2021 (8 grants) versus a trough of 1 in 2019. By volume, ART sits between Amobee, Inc. and Atomic Energy OF Canada LIMITED/ÈNERGIE Atomique DU Canada LIMITÈE.

ART's three-year grant acceleration

ART Medical Ltd. shows 13 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at ART's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows ART holds 26 patents at rank #11,536, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near ART

By rank, the assignees closest to #11,536 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in ART's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ART, neither rank-band nor same-CPC leaders (those blocks stay above). In A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…), ART ranks #34 of 903 assignees by patent count in that subclass.

ART's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201920202021202220232024 2
USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
ART Medical Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 3.8%
2020 4 15.4%
2021 8 30.8%
2022 6 23.1%
2023 5 19.2%
2024 2 7.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

ART Medical Ltd.'s patent record in context - here's where to go next.

  • ART Medical Ltd.'s lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 84.6% of its portfolio - see every assignee active in that class. Explore A61J
  • Ranked #11,551 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare ART Medical Ltd. against Amobee, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.